Cargando…
Pharmaceutical company responses to Canadian opioid advertising restrictions: A framing analysis
The pharmaceutical industry’s promotion of opioids in North America has been well-documented. Yet despite the clear consequences of improperly classifying pharmaceutical company messaging and frequently permissive approaches that allow the pharmaceutical industry to self-regulate its own advertising...
Autores principales: | Eisenkraft Klein, Daniel, Lexchin, Joel, Sud, Abhimanyu, Bavli, Itai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310031/ https://www.ncbi.nlm.nih.gov/pubmed/37384735 http://dx.doi.org/10.1371/journal.pone.0287861 |
Ejemplares similares
-
The Pharmaceutical Industry and the Canadian Government: Folie à Deux
por: Lexchin, Joel
Publicado: (2017) -
Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
por: Lexchin, Joel
Publicado: (2018) -
Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
por: Lexchin, Joel
Publicado: (2021) -
Direct-to-consumer advertising of prescription medications: what the Canadian medical trainee needs to know
por: Elfassy, Michael D., et al.
Publicado: (2019) -
Cannabis companies and the sponsorship of scientific research: A cross-sectional Canadian case study
por: Grundy, Quinn, et al.
Publicado: (2023)